Bill Gates And Cathie Wood Have This One Stock In Common, And She Just Bought Some More - ARK Genomic Rev

Cathie Wood-led Ark Investment Management on Thursday bought 162,276 shares of Schrodinger Inc (NASDAQ:SDGR) through the Ark Genomic Revolution ETF (BATS:ARKG), trading disclosure by the firm showed. The purchase is valued at over $4.6 million based on Thursday's closing price.

Schrodinger is the ninth largest holding in the ARK Genomic Revolution ETF valued at over $104 million with a weight of 3.78%. The company provides software platform for drug and materials discovery and counts Microsoft Inc. (NASDAQ:MSFT) co-founder Bill Gates' among long-term backers.

The company reported in early August second-quarter revenue of $38.5 million compared with $29.8 million in the same period last year. It guided to a full-year revenue to $161 million-$181 million, representing 17-31% percent growth.

Schrodinger recently appointed Geoffrey Porges as its chief financial officer.

Also Read: Alibaba, Other Hong Kong Stocks Show Optimism In Early Trade Even As Analysts Downgrade China Growth Projections

Cathie Wood also bought over 1 million shares of biotech firm Ginkgo Bioworks Holdings Inc (NYSE:DNA), valued at over $3.7 million, through two of Ark’s ETFs.

Ginkgo Bioworks is the 17^th largest holding in the firm’s flagship ARK Innovation ETF (NYSE:ARKK) with a weight of 2.39%.

Key Disposals: Wood sold 313,211 shares of Signify Health Inc (NYSE:SGFY), via two of the firm’s ETFs, valued at over $6.8 million based on Thursday’s closing price.

Wood sold Twitter Inc. (NYSE:TWTR) shares yet again on Thursday, selling 50 shares valued at $2,193.

ARKGARK Genomic Revolution ETF

DNAGinkgo Bioworks Holdings Inc

$8.28-1.90%

ARKKARK Innovation ETF

$79.18-0.15%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.